These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3756701)

  • 41. National vaccine injury compensation program: calculation of average cost of a health insurance policy. Final rule.
    Health Resources and Services Administration (HRSA), HHS
    Fed Regist; 2007 Jul; 72(128):36610-2. PubMed ID: 17674490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Guidelines for assessment of vaccine coverage in children. Report of the Canadian Pediatric Society.
    Can Commun Dis Rep; 1993 Nov; 19(21):180-2. PubMed ID: 8298580
    [No Abstract]   [Full Text] [Related]  

  • 43. The National Vaccine Injury Compensation Program.
    Engel NS
    MCN Am J Matern Child Nurs; 1990; 15(2):109. PubMed ID: 2108292
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunization injuries: proposed compensatory mechanisms--an analysis.
    Ohta LC
    Conn Law Rev; 1978; 11(1):147-79. PubMed ID: 11665022
    [No Abstract]   [Full Text] [Related]  

  • 45. Recent trends in pediatric Haemophilus influenzae type B infections in Canada. Immunization Monitoring Program, Active (IMPACT) of the Canadian Paediatric Society and the Laboratory Centre for Disease Control.
    Scheifele DW
    CMAJ; 1996 Apr; 154(7):1041-7. PubMed ID: 8625025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Report of Ad Hoc Commission on vaccine injury compensation. AMA Board of Trustees.
    Conn Med; 1985 Mar; 49(3):172-6. PubMed ID: 3987270
    [No Abstract]   [Full Text] [Related]  

  • 47. Administrative compensation of medical injuries: a hardy perennial blooms again.
    Barringer PJ; Studdert DM; Kachalia AB; Mello MM
    J Health Polit Policy Law; 2008 Aug; 33(4):725-60. PubMed ID: 18617673
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nomenclature for congenital and paediatric cardiac disease: historical perspectives and The International Pediatric and Congenital Cardiac Code.
    Franklin RC; Jacobs JP; Krogmann ON; Béland MJ; Aiello VD; Colan SD; Elliott MJ; William Gaynor J; Kurosawa H; Maruszewski B; Stellin G; Tchervenkov CI; Walters Iii HL; Weinberg P; Anderson RH
    Cardiol Young; 2008 Dec; 18 Suppl 2():70-80. PubMed ID: 19063777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Editorial: On immunization warnings.
    Trout ME
    J Leg Med (N Y); 1975 Apr; 3(4):7. PubMed ID: 1079232
    [No Abstract]   [Full Text] [Related]  

  • 50. Guidelines for reporting adverse events associated with vaccine products. Division of Immunization, Bureau of Infectious Diseases, Laboratory Center for Disease Control.
    Can Commun Dis Rep; 2000 Feb; 26 Suppl 1():I-IV, 1-18. PubMed ID: 11055081
    [No Abstract]   [Full Text] [Related]  

  • 51. Liability for vaccine related injuries: public health considerations and some reflections on the swine flu experience.
    Baynes TE
    St Louis Univ Law J; 1977; 21(1):44-75. PubMed ID: 11664802
    [No Abstract]   [Full Text] [Related]  

  • 52. Technologies that make administration of vaccines safer.
    Clements CJ; Larsen G; Jodar L
    Vaccine; 2004 May; 22(15-16):2054-8. PubMed ID: 15121322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Vaccination plan for children. Recommendations of the German Society for Social Pediatrics and the German Green Cross].
    Bock E; Nitsch K
    Ther Ggw; 1974 Aug; 113(8):1298, 300-2. PubMed ID: 4411467
    [No Abstract]   [Full Text] [Related]  

  • 54. Standards for child and adolescent immunization practices. National Vaccine Advisory Committee.
    National Vaccine Advisory Committee
    Pediatrics; 2003 Oct; 112(4):958-63. PubMed ID: 14523192
    [No Abstract]   [Full Text] [Related]  

  • 55. Statutory compensation urged.
    Nature; 1985 Aug 8-14; 316(6028):476-7. PubMed ID: 4033748
    [No Abstract]   [Full Text] [Related]  

  • 56. The vaccine dilemma.
    Kitch EW
    Issues Sci Technol; 1986; 2(2):108-21. PubMed ID: 11649683
    [No Abstract]   [Full Text] [Related]  

  • 57. National advisory committee on immunization (NACI). Statement on hepatitis B vaccine.
    Can Commun Dis Rep; 1993 Jul; 19(14):104-15. PubMed ID: 8364441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Update on vaccine liability in the United States: presentation at the National Vaccine Program Office Workshop on strengthening the supply of routinely recommended vaccines in the United States, 12 February 2002.
    Evans G
    Clin Infect Dis; 2006 Mar; 42 Suppl 3():S130-7. PubMed ID: 16447135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FDA approval for infants of a Haemophilus influenzae type b conjugate and hepatitis B (recombinant) combined vaccine.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Feb; 46(5):107-9. PubMed ID: 9045037
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Compensation for vaccine injury.
    Kendig EL
    Va Med; 1988 Apr; 115(4):175. PubMed ID: 3369231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.